Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labelingCHENG, Hong-Lin; HUANG, Hung-Jen; OU, Bing-Yuan et al.Proteomics. Clinical applications (Print). 2011, Vol 5, Num 3-4, pp 121-132, issn 1862-8346, 12 p.Article

Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate CancerCHIU, Hui-Wen; CHEN, Mei-Huei; FANG, Wen-Hung et al.Journal of agricultural and food chemistry (Print). 2013, Vol 61, Num 18, pp 4379-4386, issn 0021-8561, 8 p.Article

Effects of intermediate-conductance Ca²⁺-activated K⁺ channel modulators on human prostate cancer cell proliferationPARIHAR, Ashutosh S; COGHLAN, Michael J; GOPALAKRISHNAN, Murali et al.European journal of pharmacology. 2003, Vol 471, Num 3, pp 157-164, issn 0014-2999, 8 p.Article

What patients take without telling you : holistic approach for BPH : BPH management at the turn of the twenty-first century: evolution or revolutionCAPODICE, Jillian L; KATZ, Aaron E.World journal of urology (Print). 2006, Vol 24, Num 4, pp 378-382, issn 0724-4983, 5 p.Article

Laparoscopic extraperitoneal adenomectomy (Millin): Pilot study on feasibility. CommentaryVAN VELTHOVEN, R; PELTIER, A; LAGUNA, M. P et al.European urology. 2004, Vol 45, Num 1, pp 103-109, issn 0302-2838, 7 p.Article

About-weekly variations in nocturiaCORNELISSEN, Germaine; AXELROD, David E; HALBERG, Franz et al.Biomedicine & pharmacotherapy. 2004, Vol 58, pp S140-S144, issn 0753-3322, SUP1Conference Paper

Total flavan glycoside from Abacopteris penangiana rhizomes and its acid hydrolysate: Characterisation and anti-benign prostatic hyperplasia potentialHAN WEI; GUANGHUA WU; DU SHI et al.Food chemistry. 2012, Vol 134, Num 4, pp 1959-1966, issn 0308-8146, 8 p.Article

Banana Peel Extract Suppressed Prostate Gland Enlargement in Testosterone-Treated MiceAKAMINE, Kiichiro; KOYAMA, Tomoyuki; YAZAWA, Kazunaga et al.Bioscience, biotechnology, and biochemistry. 2009, Vol 73, Num 9, pp 1911-1914, issn 0916-8451, 4 p.Article

How do intermediate endpoint markers respond to lycopene in men with prostate cancer or benign prostate hyperplasia?VAN BREEMEN, Richard B.The Journal of nutrition. 2005, Vol 135, Num 8, pp 2062S-2064S, issn 0022-3166Conference Paper

Bleeding after holmium laser enucleation of the prostate: Lessons learned the hard wayMARTIN, Aaron D; NUNEZ, Rafael N; HUMPHREYS, Mitchell R et al.BJU international (Papier). 2011, Vol 107, Num 3, pp 433-437, issn 1464-4096, 5 p.Article

Serum sex hormones and measures of benign prostatic hyperplasiaROBERTS, Rosebud O; JACOBSON, Debra J; RHODES, Thomas et al.The Prostate. 2004, Vol 61, Num 2, pp 124-131, issn 0270-4137, 8 p.Article

Transarterial Prostatic Embolization: Initial Experience in a Canine ModelFEI SUN; SANCHEZ, Francisco M; CRISOSTOMO, Veronica et al.American journal of roentgenology (1976). 2011, Vol 197, Num 2, pp 495-501, issn 0361-803X, 7 p.Article

Complications of laser prostatectomy: a review of recent data : Management of BPH in 2010 (Treatment)RIEKEN, Malte; EBINGER MUNDORFF, Nicole; BONKAT, Gernot et al.World journal of urology (Print). 2010, Vol 28, Num 1, pp 53-62, issn 0724-4983, 10 p.Article

Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostateBACH, T; WENDT-NORDAHL, G; MICHEL, M. S et al.World journal of urology (Print). 2009, Vol 27, Num 4, pp 541-545, issn 0724-4983, 5 p.Article

Silodosin for Benign Prostatic HyperplasiaCANTRELL, Matthew A; BREAM-ROUWENHORST, Heather R; HEMERSON, Phyllis et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 2, pp 302-310, issn 1060-0280, 9 p.Article

Expression of mRNA for human type-I LHRH receptor transcript forms in human benign prostatic hyperplasiaROZSA, Bernadett; JUHASZ, Aliz; TRESZL, Andrea et al.International journal of oncology. 2009, Vol 35, Num 5, pp 1053-1059, issn 1019-6439, 7 p.Article

Photoselective vaporization of the prostate in the therapy of benign prostatic hyperplasiaKAMALOV, A. A; OSMOLOVSKIY, B. E.Journal of men's health. 2008, Vol 5, Num 2, pp 148-152, 5 p.Article

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?KRAMER, Gero; MITTEREGGER, Dieter; MARBERGER, Michael et al.European urology. 2007, Vol 51, Num 5, pp 1202-1216, issn 0302-2838, 15 p.Article

Current role of lasers in the treatment of benign prostatic hyperplasia (BPH)KUNTZ, Rainer M.European urology. 2006, Vol 49, Num 6, pp 961-969, issn 0302-2838, 9 p.Article

Transvesical Robotic Simple Prostatectomy: Initial Clinical ExperienceLESLIE, Scott; DE CASTRO ABREU, Andre Luis; CHOPRA, Sameer et al.European urology. 2014, Vol 66, Num 2, pp 321-329, issn 0302-2838, 9 p.Article

Eraser Laser Enucleation of the Prostate: Technique and ResultsHRUBY, Stephan; SIEBERER, Manuela; SCHÄTZ, Tobias et al.European urology. 2013, Vol 63, Num 2, pp 341-346, issn 0302-2838, 6 p.Article

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic reviewMACDONALD, Roderick; TACKLIND, James W; RUTKS, Indulis et al.BJU international (Papier). 2012, Vol 109, Num 12, pp 1756-1761, issn 1464-4096, 6 p.Article

Photoselective vaporization of the prostate using the 120-W lithium triborate laser in enlarged prostates (120 cc)WOO, Henry H.BJU international (Papier). 2011, Vol 108, Num 6, pp 860-863, issn 1464-4096, 4 p.Article

An insidious risk factor for cardiovascular disease: Benign prostatic hyperplasiaKARATAS, Omer Faruk; BAYRAK, Omer; CIMENTEPE, Ersin et al.International journal of cardiology. 2010, Vol 144, Num 3, issn 0167-5273, p. 452Article

A novel nonsecosteroidal VDR agonist (CH5036249) exhibits efficacy in a spontaneous benign prostatic hyperplasia beagle modelTANIGUCHI, K; KATAGIRI, K; KATO, A et al.Journal of steroid biochemistry and molecular biology. 2010, Vol 121, Num 1-2, pp 204-207, issn 0960-0760, 4 p.Conference Paper